Compare Novartis AG (NVS) vs Ralph Lauren Corp (RL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Ralph Lauren Corp — how do they compare? Novartis AG trades at $149.81 (market cap $290.25B), while Ralph Lauren Corp trades at $375.67 (market cap $22.41B). The key difference: Novartis AG is far larger — about 13× Ralph Lauren Corp's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | RL | |
|---|---|---|
Market Cap | $290.25B | $22.41B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $414.25 |
52-Week Low | $113.50 | $283.34 |
Enterprise Value | $330.27B | $23.35B |
Dividend Yield | 3.17% | 0.99% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Ralph Lauren Corp
Founded by designer Ralph Lauren in 1967, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, leather goods, home products, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, Lauren Ralph Lauren, and Double RL. Distribution channels for Ralph Lauren include wholesale (including department stores and specialty stores), retail (including company-owned retail stores and e-commerce), and licensing.
Read more on RL →
